Cataract Fighting Team Wins PrizeAdelaide based Calpain Therapeutics has won the annual Enterprize business plan contest run by Queensland Business School. Their pitch was to develop a drug to delay cataract growth by targeting a particular protein in the eye's tissue thought to cause clouding of the eye's lens. The company is very grateful for the money which will be used to fund human lens experiments, vital in understanding more about cataracts.
Aspirin may cause AMDEuropean Eye Study researchers suspect that frequent aspirin use can make Age-related Macular degeneration more likely. According to an analysis of 4691 subjects 65 years or older, participants who used aspirin daily had an increased occurrence of AMD. However, the study was not conclusive as it was unknown the dosage of each aspirin taken, and the possibility that subjects may have started taking aspirin after experiencing visual problems.
Tiny robot to give treatment to DR sufferers.A new technology has allowed optometrists to consider implanting a sort of robot in a Diabetic Retinpathy sufferer. The primary purpose would be for it to release a dosage of docetaxel into the back of the eye. With no batteries and powered by a magnetic field, it can last for more than 35 days without any leakage or problems. Testing is still underway.